<html>
  <head>
    <title>
      CellProfiler impact on human health
    </title>
    <meta content="text/html; charset=utf-8" http-equiv="Content-Type" />
    <link rel="stylesheet" href="stylesheets/application.css">
    <link href=
    'https://fonts.googleapis.com/css?family=Source+Code+Pro:400|Roboto:400,300,500'
    rel='stylesheet' type='text/css' />



    <style type="text/css">

    div.boxed {background:#CCCCFF;color:#000;display:inline-block}

    </style>
    <link href="NiftyCube/niftyCorners.css" rel="stylesheet" type="text/css" />
    <script type="text/javascript">
    //

    var _gaq = _gaq || [];
    _gaq.push(['_setAccount', 'UA-4307992-1']);
    _gaq.push(['_trackPageview']);

    (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
    })();

    //
    </script>
  </head>
  <body onload=
  "clientSideInclude('header','header.txt'); clientSideInclude('footer','footer.txt'); document.getElementById('header_aboutus').id='current';">
  <div id="mainwrapper">
      <div id="header">
        <div>
          <a href="/"><img border="0" class="header1" src=
          "http://d1zymp9ayga15t.cloudfront.net/images/cp_logo_smaller.png" width="400" /></a> <a href=
          "http://www.broadinstitute.org/"><img alt="Broad Institute logo"
          border="0" class="header2" height="68" src=
          "http://d1zymp9ayga15t.cloudfront.net/images/BroadInstituteLogo_smaller.png" width="220" /></a>
          <div id="navigation">
            <hr />

            <ul>
              <li>
                <a href="/" id="header_main">home</a>
              </li>

              <li>
                <a href="#" id="header_getting_started" onclick=
                "return false;">getting started</a>
                <ul>
                  <li>
                    <a href="/faq.html">What is CellProfiler? FAQ</a>
                  </li>

                  <li>
                    <a href="/examples.html">examples</a>
                  </li>

                  <li>
                    <a href="/tutorials.html">tutorials</a>
                  </li>

                  <li>
                    <a href=
                    "http://d1zymp9ayga15t.cloudfront.net/content/CellProfilerSoftwareBrochure.pdf">brochure</a>
                  </li>
                </ul>
              </li>

              <li>
                <a href="#" id="header_download" onclick=
                "return false;">download</a>
                <ul>
                  <li>
                    <a href="/download.html">CellProfiler</a>
                  </li>

                  <li>
                    <a href="/downloadCPA.html">CellProfiler Analyst</a>
                  </li>
                </ul>
              </li>

              <li style="width:109px;text-align:center;">
                <a href="#" id="header_help" onclick="return false;">help</a>
                <ul>
                  <li>
                    <a href="http://forum.cellprofiler.org/">forum</a>
                  </li>

                  <li>
                    <a href="/supportplan.html">support plan</a>
                  </li>

                  <li>
                    <a href="http://www.broadinstitute.org/bbbc/">BBBC</a>
                  </li>

                  <li>
                    <a href=
                    "https://github.com/CellProfiler/CellProfiler/wiki">for
                    developers</a>
                  </li>

                  <li>
                    <a href="/manuals.html">manuals</a>
                  </li>

                  <li>
                    <a href="/wormtoolbox">WormToolbox</a>
                  </li>

                  <li>
                    <a href="/imagingflowcytometry">Imaging Flow Cytometry</a>
                  </li>
                </ul>
              </li>

              <li>
                <a href="#" id="header_aboutus" onclick="return false;">about
                us</a>
                <ul>
                  <li>
                    <a href="/about.html">CellProfiler Team</a>
                  </li>

                  <li>
                    <a href="/impact.html">impact</a>
                  </li>

                  <li>
                    <a href="/press.html">press</a>
                  </li>

                  <li>
                    <a href="/citations.html">citations</a>
                  </li>

                  <li>
                    <a href="/outreach.html">outreach</a>
                  </li>

                  <li>
                    <a href="/interfaces.html">interfaces</a>
                  </li>

                  <li>
                    <a href="/#CurrentNews">news</a>
                  </li>
                </ul>
              </li>

              <li class="navsearch">
                <form action="http://google.com/search" method="get" onsubmit=
                "location.href = this.action + '?&q=%2Bsite:cellprofiler.org+' + this.query.value; return false;">
                <input maxlength="255" name="query" size="20" type="text"
                  value="" /> <input type="submit" value="search" />
                </form>
              </li>
            </ul>
            <br />

            <hr style="clear:left" />
          </div>
        </div>
      </div>

      <div id="content">
        <h1>
          Impact on human health
        </h1>

        <p>
          Our CellProfiler software has yielded discoveries in several
          translational projects, some of which may ultimately have a direct
          impact on the treatment of disease. For example, CellProfiler has
          been used to identify several small molecules that are effective in
          treating particular diseases in mouse models. In some cases,
          discoveries made using CellProfiler have even led to planning
          clinical trials in humans, which could directly improve patient
          outcomes. Here we highlight instances that have come to our
          attention. [See also: <a href=
          "http://cellprofiler.org/citations.html">citations]</a>
        </p>

        <h2 style="font-style:italic;">
          Ebola Virus
        </h2>
        <a href="https://www.flickr.com/photos/niaid/16441626349/"><img alt=
        "CellProfiler Ebola disease image" src="http://d1zymp9ayga15t.cloudfront.net/images/ebola.png" style=
        "float:right; padding-left:10px;" width="160" /></a>
        <p>
          The 2014 outbreak of the Ebola virus in West Africa has claimed the
          lives of over 8,600 people worldwide; the disease currently has no
          approved cure or vaccine. CellProfiler was used to identify
          therapeutic targets within host human macrophages capable of halting
          infection by inhibiting viral uptake via cell surface proteins and
          endosomal trafficking. The <a href=
          "http://www.txbiomed.org/departments/virology/virology-staff-bio/?u=185">
          Davey</a> lab at the Texas Biomedical Research Institute found that
          Tetrandrine, an isolate from Chinese and Japanese herbs but now
          produced synthetically, was especially potent in blocking two-pore
          channels found in endosomes, and preliminary studies showed high
          therapeutic efficacy in mice without obvious side effects.
        </p>

        <p>
          <span style="font-style:italic;">For more details</span>: Sakurai Y
          et al. (2015) Two-pore channels control Ebola virus host cell entry
          and are drug targets for disease treatment. Science, 347(6225)
          995-998 (<a href=
          "http://www.sciencemag.orghttp://d1zymp9ayga15t.cloudfront.net/content/347/6225/995.full">paper</a>,
          <a href=
          "http://www.txbiomed.org/news-press/detail/news/2015/02/26/research-shows-asian-herb-holds-promise-as-treatment-for-ebola-virus-disease">
          press release</a>)
        </p>
        <br />

        <h2 style="font-style:italic;">
          Tuberculosis
        </h2>
        <img alt="Mycobacterium tuberculosis (Mtb) CellProfiler image-analysis"
        src="http://d1zymp9ayga15t.cloudfront.net/images/Tuberculosis.png" style="float:right; padding-left:10px;"
        width="160" />
        <p>
          Tuberculosis (TB) is a disease of global concern due in part to
          increasingly antibiotic-resistant bacteria. CellProfiler was used in
          a high-throughput screen of bioactive small molecules to identify
          those that inhibited growth of Mycobacterium tuberculosis (Mtb)
          within host cells by targeting host functions and pathways. Notably,
          among the identified effective compounds were fluoxetine (commonly
          known as Prozac) and gefitinib, used clinically for treating
          depression and cancer, respectively. Gefitinib was subsequently
          demonstrated to reduce Mtb growth in the lungs of infected mice. In
          addition to identifying new pathways likely to be relevant for TB
          pathogenesis, this work demonstrated that targeting the host may be a
          viable adjunctive approach for treating TB.
        </p>

        <p>
          <span style="font-style:italic;">For more details</span>: Stanley SA
          et al. (2014). A chemical screen to identify host-targeting small
          molecules that restrict intracellular Mycobacterium tuberculosis
          growth. PLoS Pathogens, 10(2):e1003946 (<a href=
          "http://dx.doi.org/10.1371/journal.ppat.1003946">paper</a>)
        </p>
        <br />

        <h2 style="font-style:italic;">
          Leukemia (AMKL)
        </h2>
        <img alt="CellProfiler Leukemia human megakaryocytes image analysis"
        src="http://d1zymp9ayga15t.cloudfront.net/images/Polyploidy.png" style="float:right; padding-left:10px;"
        width="160" />
        <p>
          CellProfiler helped to identify novel compounds that may lead to
          potential treatments for a form of leukemia involving human
          megakaryocytes (AMKL). Most cancer treatments work by targeting
          cancer cells for death as compared to normal cells. By contrast, the
          goal here was to search for drugs that can induce polyploidy, which
          restrains the cancerous cells’ uncontrolled growth by causing them to
          differentiate into a terminal state. Over 200 polyploidization
          regulators were identified from a 10,000 compound screen. One hit in
          particular, dimethylfasudil, a broad kinase inhibitor of Aurora
          kinase A, also succeeded in inducing polyploidy in an AMKL mouse
          model. The team turned its attention to the Aurora-A inhibitor
          Alisertib which is already under clinical investigation for a variety
          of tumors.
        </p>

        <p>
          <span style="font-style:italic;">For more details</span>: Wen Q et
          al. (2012). Identification of regulators of polyploidization presents
          therapeutic targets for treatment of AMKL. Cell, 150(3):575-89
          (<a href="http://dx.doi.org/10.1016/j.cell.2012.06.032">paper</a>,
          <a href="http://www.broadinstitute.org/news/4289">press release</a>).
        </p>
        <br />

        <h2 style="font-style:italic;">
          Leukemia Stem Cells
        </h2>
        <img alt="CellProfiler Leukemia Leukemic stem cells image analysis"
        src="http://d1zymp9ayga15t.cloudfront.net/images/Cobblestones.png" style="float:right; padding-left:10px;"
        width="160" />
        <p>
          Cancer treatments directed towards leukemia can often fail due to the
          survival of leukemic stem cells (LSCs) in the bone marrow. The
          researchers screened 14,000 compounds in an unusually complex and
          physiologically relevant in vitro co-culture system involving bone
          marrow stromal cells and primary LSC-enriched cells. CellProfiler was
          used together with the machine-learning capabilities of CellProfiler
          Analyst to find compounds that inhibit LSC growth but do not affect
          normal hematopoietic stem cells. One of the identified compounds was
          lovastatin, a drug commonly used to treat high cholesterol. It
          inhibited LSC growth in the co-culture system, as well as extended
          the survival of mice with lovastatin-treated leukemic bone marrow
          cells.
        </p>

        <p>
          <span style="font-style:italic;">For more details</span>: Hartwell KA
          et al. (2013) Nat Chem Biol, 9(12):840-8 (<a href=
          "http://dx.doi.org/10.1038/nchembio.1367">paper</a>, <a href=
          "http://www.broadinstitute.org/news/5323">press release</a>).
        </p>
        <br />

        <h2 style="font-style:italic;">
          Cerebral Cavernous Malformation (CCM)
        </h2>
        <a href=
        "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356181/"><img alt="CellProfiler Cerebral Cavernous Malformation image analysis"
        src="http://d1zymp9ayga15t.cloudfront.net/images/CCM.jpg" style="float:right; padding-left:10px;" width=
        "160" /></a>
        <p>
          Researchers at the <a href=
          "http://www.bioscience.utah.edu/faculty/molecular-biology-faculty/li/li.php">
          University of Utah</a> used CellProfiler to identify image-based
          phenotypes associated with a monogenic rare disease, the hereditary
          stroke syndrome cerebral cavernous malformation (CCM). They then
          identified known drugs that could reverse the phenotype and
          demonstrated efficacy in a mouse model of CCM disease. This led to
          the launching of <a href="http://www.recursionpharma.com/">Recursion
          Pharmaceuticals</a>, which is pursuing a clinical trial for a
          compound to treat CCM, which has no currently approved therapy. The
          company will use a similar approach to identify compounds to target
          other rare genetic diseases.
        </p>

        <p>
          <span style="font-style:italic;">For more details</span>: Gibson CC
          et al. (2015) Strategy for identifying repurposed drugs for the
          treatment of cerebral cavernous malformation. Circulation,
          131(3):289-99 (<a href=
          "http://circ.ahajournals.orghttp://d1zymp9ayga15t.cloudfront.net/content/early/2014/12/04/CIRCULATIONAHA.114.010403.abstract">paper</a>)
        </p>
        <br />
      </div>

      <div id="footer">
        <div>
          <center>
            <img alt="Banner" src="http://d1zymp9ayga15t.cloudfront.net/images/banner_small.png" style=
            "margin-top:20px" width="100%" />
          </center>
        </div>
      </div>
    </div>
    <!-- Piwik -->
    <script type="text/javascript">
    //
    var _paq = _paq || [];
    _paq.push(['trackPageView']);
    _paq.push(['enableLinkTracking']);
    (function() {
    var u="//159.203.72.67/piwik/";
    _paq.push(['setTrackerUrl', u+'piwik.php']);
    _paq.push(['setSiteId', 1]);
    var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
    g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
    })();
    //
    </script> <noscript>
    <p>
      <img alt="" src="//159.203.72.67/piwik/piwik.php?idsite=1" style=
      "border:0;" />
    </p></noscript> <!-- End Piwik Code -->
  </body>
</html>
